Buradasınız

Anasayfa » Content

Asemptomatik vajinal akıntı ile belirlenen uterin karsinosarkom; nadir bir olgu

Uterine carcinosarcoma presented with asymptomatic vaginal discharge; a rare case

Journal Name:

  • Abant Tıp Dergisi

Publication Year:

  • 2013

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Uterine carcinosarcoma also known as malignant mixed mullerian tumor (MMMT) of uterus is very rare but highly aggressive neoplasm that usually arises in postmenopausal age group. Carcinosarcoma is no longer classified uterine sarcomas subgroup. Today it is accepted as a metaplastic carcinoma. In this case we present a 71 year-old patient with 1-month history of pale vaginal discharge. Transvaginal ultrasonography revealed endometrial thickness of 28mm in polypoid appeareance and myometrial heterogeneity. En-dometrial curettage was performed. Hystopathologic result was reported as a carcinosarcoma. Here in we discussed an uterine carcinosarcoma of a postmenapausal woman who is represented with asymptomatic vaginal discharge according to the current literature.
Bookmark/Search this post with
Abstract (Original Language): 
Karsinosarkom diğer adı ile malign mikst müllerian tümör (MMMT), nadir görülen, agresif seyirli, genelde postmeno-pozal yaşlarda oluşan bir neoplazidir. Karsinosarkom daha önceleri uterin sarkomların alt grubu olarak sınıflandırılma-sına rağmen günümüzde metaplastik karsinom olarak kabul edilmektedir. 71 yaşındaki hasta 1 aydır olan şeffaf renkli akıntı şikayeti ile polikliniğe başvurdu. Yapılan transvajinal ultrasonografide endometriyum 28 mm, polipoid görünüm-de ve miyometriyum heterojen olarak izlendi. Hastaya probe kürataj yapıldı. Histopatoloji sonucu karsinosarkom olarak rapor edildi. Bu olgu sunumunda postmenopozal asempto-matik vajinal akıntı ile başvuran hastadaki uterin karsinosar-kom vakası güncel litaratür eşliğinde tartışılmıştır.
FULL TEXT (PDF): 
PDF icon arastirmax-asemptomatik-vajinal-akinti-ile-belirlenen-uterin-karsinosarkom-nadir-bir-olgu.pdf
  • 3
235
237
  • Turkish

REFERENCES

References: 

1. Brooks SE, Zhan M, Cote T, Baquet CR: Surveillance, epi-demiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 2004;93:204-208.
2. Tse KY, Crawford R, Ngan HY: Staging of uterine sarco-mas. Best Pract Res Clin Obstet Gynaecol 2011;25:733-749.
3. Prat J: Figo staging for uterine sarcomas. Int J Gynaecol Obstet 2009;104:177-178.
4. Schweizer W, Demopoulos R, Beller U, Dubin N: Prognos-tic factors for malignant mixed mullerian tumors of the uterus. Int J Gynecol Pathol 1990;9:129-136.
5. Harlow BL, Weiss NS, Lofton S: The epidemiology of sar-comas of the uterus. J Natl Cancer Inst 1986;76:399-402.
6. McCluggage WG: Uterine carcinosarcomas (malignant mixed mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 2002;12:687-690.
7. Ferrandina G, Zannoni GF, Martinelli E, Vellone V, Prisco MG, Scambia G: Endometrial carcinoma recurring as carci-nosarcoma: Report of two cases. Pathol Res Pract 2007;203:677-681.
8. Buza N, Tavassoli FA: Comparative analysis of p16 and p53 expression in uterine malignant mixed mullerian tu-mors. Int J Gynecol Pathol 2009;28:514-521.
9. Mikami Y, Hata S, Kiyokawa T, Manabe T: Expression of cd10 in malignant mullerian mixed tumors and adenosar-comas: An immunohistochemical study. Mod Pathol 2002;15:923-930.
10. Gadducci A, Cosio S, Romanini A, Genazzani AR. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol. 2008;65: 129-42.

Thank you for copying data from http://www.arastirmax.com